Mobile Menu

Search Results

Search results for: Drug Administration

New Alzheimer’s Drug Data Issues

Earlier this week the U.S. Food and Drug Administration approved the first new treatment for Alzheimer’s disease in almost 20 […]

IBDREAM Registry – Adverse Drug Reactions from Real-World Data in IBD

A recent study, published in Drug Safety, aimed to describe the adverse drug reactions reported in inflammatory bowel disease patients […]

AI Drug Discovery Screening Reveals Zafirlukast as a COVID-19 Repurposing Candidate

A recent study, published in Medicine Drug Discovery, has used AI-driven drug discovery screening to identify repurposing candidates among FDA-approved […]

Reach for the stars: Star-shaped device releases drugs more efficiently

Researchers from John Hopkins have developed a star-shaped device that can latch onto intestinal mucosa and release drugs into the […]

Drug repurposing in Alzheimer’s disease

A recent review, in Nature Reviews Neurology, has provided an overview of the promising compounds for clinical trials in individuals […]

Multi-target drug design against schizophrenia

A recent review, published in Expert Opinion on Drug Discovery, has explored our current understanding of schizophrenia and the applications […]

Overview of drug repositioning

A recent review, published in the Journal of Pharmacy and Pharmacology, provides an overview of drug repositioning and the new […]

Are ‘virtual patients’ the future of clinical trials?

Researchers have demonstrated that an in-silico approach, using virtual patient data, was able to replicate clinical trial results and investigate […]

Side effect profile of clozapine using RWD

We summarise a recent study that used real-world data (RWD) to explore the prevalence of adverse effects in patients before […]

May pharma-published AI and Real World Evidence articles

Benjamin Hughes, Senior Vice President of Artificial Intelligence and Real World Data at IQVIA, has again collated the leading AI […]